BNP Paribas Financial Markets
SLS icon

BNP Paribas Financial Markets’s SELLAS Life Sciences SLS Stock Holding History

BNP Paribas Financial Markets’s Portfolio SLS Stock Details SLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.8M Buy
1,072,022
+1,025,006
+2,180% +$7.08M 0.01% 1363
2026
Q1 		$199K Buy
47,016
+20,178
+75% +$90.3K ﹤0.01% 4054
2025
Q4 		$101K Buy
26,838
+7,114
+36% +$13.8K ﹤0.01% 4370
2025
Q3 		$31.8K Buy
19,724
+9,299
+89% +$16.6K ﹤0.01% 4782
2025
Q2 		$22.8K Buy
+10,425
New +$16K ﹤0.01% 4539
2017
Q4 		– Hold
0
– -$1 – 4293
2017
Q3 		– Hold
0
– – – 4239
2017
Q2 		– Hold
0
– – – 4257

Other funds holding SLS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $1.68B AUM 374.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Jones Financial Companies
Jones Financial Companies Des Peres, Missouri $250B AUM 21.32% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

BNP Paribas Financial Markets's SLS Position: Q2 2026 in Review

BNP Paribas Financial Markets increased its SELLAS Life Sciences (SLS) stake by 2,180% in Q2 2026, buying an estimated $7.08M and bringing the position to 1,072,022 shares worth $15.8M. The position accounts for 0.01% of the portfolio, ranked #1363.

BNP Paribas Financial Markets first reported a position in SLS in Q2 2025 and has held it in 5 quarters since. 180 funds tracked by Wall St. Rank hold SLS as of Q2 2026.

  • BNP Paribas Financial Markets held 1,072,022 shares of SELLAS Life Sciences worth $15.8M as of Q2 2026.
  • BNP Paribas Financial Markets bought 1,025,006 SELLAS Life Sciences shares in Q2 2026, an estimated $7.08M.
  • SELLAS Life Sciences made up 0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #1363 holding.
  • BNP Paribas Financial Markets first reported a position in SELLAS Life Sciences in Q2 2025 and has held it in 5 quarters since.
  • 180 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.